Whole-body insulin sensitivity was ultimately impaired, accompanied by a chronic state of subclinical systemic inflammation, and the development of an array of obesity-related complications including CVD and cardiovascular mortality (Table 1). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.